AnelleO — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

AnelleO is a private, pre-revenue biotech founded in 2017, focusing on advanced drug-device combinations for women's health. Its core innovation is a proprietary 3D printing platform, utilizing Digital Light Synthesis (DLS) from Carbon, Inc., to manufacture geometrically complex IVRs with precise control over drug release kinetics for small and large molecules. The company is positioned as a potential partner for pharmaceutical companies seeking to enhance or enable new therapies through its rapid, scalable, and tunable delivery platform, targeting a significant gap in the women's health market.

Women's Health

Technology Platform

Proprietary 3D printing platform using Digital Light Synthesis (DLS) to manufacture geometrically complex intravaginal rings (IVRs) for tunable, sustained delivery of small and large molecules, including biologics.

Opportunities

The significant, underserved women's health market creates a major opportunity for novel drug delivery platforms.

AnelleO's ability to rapidly customize IVRs for partner molecules could enable new therapies, enhance existing ones, and create valuable, patent-protected combination products through a capital-efficient partnership model.

Risk Factors

Key risks include dependence on securing pharmaceutical partners, the technical challenge of scaling a novel 3D printing process to GMP standards, and the regulatory complexity of combination products.

Market acceptance of intravaginal delivery methods also presents an adoption risk.

Competitive Landscape

AnelleO competes with traditional IVR manufacturers (e.g., Merck's NuvaRing) and other sustained-release implant companies. Its primary differentiation is geometric tunability via 3D printing and broad molecule compatibility. Competition also comes from other drug delivery platform companies and pharmaceutical firms' internal development teams.

More companies in Drug Delivery & Formulation →More companies in United States →